Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Cavalli, A."'
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, 8:673773. Frontiers Media S.A.
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, 8:673773. Frontiers Media S.A.
nd
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine
Frontiers in Medicine
Rare diseases (RDs) are complicated health conditions that are difficult to be managed at several levels. The scarcity of available data chiefly determines an intricate scenario even for experts and specialized clinicians, which in turn leads to the
Autor:
Michele Cavalli, Laura Valentina Renna, Giovanni Meola, Luisa L. Villa, Rosanna Cardani, Mauro Toffetti
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology
Frontiers in Neurology
Mutations in the MATR3 gene are associated to distal myopathy with vocal cord and pharyngeal weakness (VCPDM), as well as familiar and sporadic motor neuron disease. To date, 12 VCPDM families from the United States, Germany, Japan, Bulgary, and Fran
Autor:
Izabela M. C. A. Conceição, Mayara Caldeira-Dias, Ricardo de Carvalho Cavalli, Marcelo R. Luizon, Valeria C. Sandrim, Sarah Viana-Mattioli
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Frontiers in Physiology
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2022-04-29T08:45:57Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-09-22 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coor
Autor:
Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri, Lorenzo Dagna
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
Coronavirus disease 2019 (COVID-19) is a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 result in acute respiratory distress syndrome and death. A detrimental, hyper-inflammatory immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765843a161afba785fb5fccbee22fb6b
Autor:
Antonio Vitale, Giulio Cavalli, Piero Ruscitti, Jurgen Sota, Serena Colafrancesco, Roberta Priori, Guido Valesini, Lorenza Maria Argolini, Elena Baldissera, Elena Bartoloni, Daniele Cammelli, Giovanni Canestrari, Elena Cavallaro, Maria Grazia Massaro, Paola Cipriani, Ginevra De Marchi, Salvatore De Vita, Giacomo Emmi, Micol Frassi, Roberto Gerli, Elisa Gremese, Florenzo Iannone, Marco Fornaro, Anna Paladini, Giuseppe Lopalco, Raffaele Manna, Alessandro Mathieu, Carlomaurizio Montecucco, Marta Mosca, Ilaria Piazza, Matteo Piga, Irene Pontikaki, Micol Romano, Silvia Rossi, Maurizio Rossini, Elena Silvestri, Chiara Stagnaro, Rosaria Talarico, Bruno Frediani, Angela Tincani, Ombretta Viapiana, Gianfranco Vitiello, Paola Galozzi, Paolo Sfriso, Carla Gaggiano, Salvatore Grosso, Donato Rigante, Lorenzo Dagna, Roberto Giacomelli, Luca Cantarini
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine, Vol 7 (2020)
Background: Aim of this study was to search for any difference in the outcome of patients with adult onset Still's disease (AOSD) treated with anakinra (ANK) in relation with the interval between disease onset and the start of anti-interleukin(IL)-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d6d49d4a1e1236726b26738e4dfe87
http://hdl.handle.net/11573/1555830
http://hdl.handle.net/11573/1555830
Autor:
Giulio Cavalli, Charles A. Dinarello
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacology, 9
Frontiers in Pharmacology
Frontiers in Pharmacology, 9
Frontiers in Pharmacology
Contains fulltext : 200576.pdf (Publisher’s version ) (Open Access) Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1alpha and IL-1beta) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondar
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology
Frontiers in Neurology
Background: The discovery of the Mirror Neuron System has promoted the development of Action Observation Therapy (AOT) to improve motor and functional abilities in patients with Parkinson's disease (PD). This innovative approach involves observing vi
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Myocarditis is defined by WHO as an inflammatory disease affecting the myocardium, diagnosed by endomyocardial biopsy (EMB) using established histological, immunological, and immunohistochemical criteria; it may be idiopathic, infectious, or autoimmu
Autor:
Michele Cavalli, Barbara Fossati, Raffaele Vitale, Elisa Brigonzi, Vito A. G. Ricigliano, Lorenzo Saraceno, Rosanna Cardani, Carlo Pappone, Giovanni Meola
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 9 (2018)
Frontiers in Neurology, Vol 9 (2018)
Skeletal muscle sodium channelopathies are a group of neuromuscular disorders associated with mutations in the SCN4A gene. Because principal sodium channel isoforms expressed in the skeletal muscles and the heart are distinct one from the other, this